openPR Logo
Press release

FlyPharma 2024: An Event to Remember

11-01-2024 12:59 PM CET | Health & Medicine

Press release from: Samedan Ltd

FlyPharma Vienna 2024 has officially concluded! The landmark event successfully united industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more. Hosted in the historic city of Vienna, this year's conference highlighted actionable solutions and groundbreaking ideas aimed at advancing the future of pharma logistics and supply chains.

The event launched with hands-on workshops, including a risk assessment session led by Bernhard Zoidl, emphasizing regulatory compliance and collaborative strategies for safeguarding pharmaceutical supply chains. Frank van Gelder, Secretary General of Pharma.Aero, also engaged attendees with a workshop on transforming business strategy into tangible plans, shedding light on the necessity of visionary planning and adaptive leadership.

Panel discussions captivated the audience by tackling some of the industry's most critical issues. Under the guidance of Céline Crahay, one panel explored synergy between contingency planning in pharma shipments and air freight crisis management, aiming to boost resilience across supply chains. Another panel, moderated by Dr. Zvonimir Majic, explored ethical and operational considerations for integrating AI into pharma logistics, focusing on advanced shipping solutions and risk management.

Keynote speakers Vatsala Sadasivan of Sanofi and Luiz Barberini of Bayer shared expert perspectives on R&D logistics and sourcing trends, providing attendees with insights into operational excellence and future developments in the field.

The key takeaways from this year's event centered on the vital role of trust and collaboration in driving forward the united goal of helping and saving lives within the pharma industry. Industry leaders underscored that transparent communication and cooperative partnerships are not merely operational tactics but essential commitments. These collaborative approaches build resilience in the supply chain, ensure ethical practices, and ultimately support life-saving efforts by ensuring critical medicines and treatments reach patients safely and efficiently.

Networking opportunities were abundant, with attendees connecting during sponsor-hosted breaks by Etihad Cargo and DoKaSch Temperature Solutions. The Exclusive Gala Dinner, sponsored by Vienna AirportCity, at Palais Ferstel was a highlight, featuring an exquisite meal and live entertainment. The conference closed with an exclusive tour of the Vienna Airport pharma cargo facilities, offering a rare look into state-of-the-art logistics operations.

FlyPharma Europe 2024 has left a lasting impact on all participants, fostering partnerships and inspiring innovation across the pharma and cargo logistics industries. Attendees left inspired by the shared commitment of improving the industry.

FlyPharma is thrilled to announce its return in 2025, at Schiphol Airport in Amsterdam. Set against the backdrop of one of Europe's busiest cargo hubs, FlyPharma Europe 2025 will continue to drive transformative conversations and connect industry leaders in pharma and logistics.

44 Maiden Ln, London WC2E 7LN

Press Contact Information:
Ellen Taurich, Conference Producer, email: ellen@samedanltd.com
Simon Caplan, Sponsorship Opportunities, email: simon@samedanltd.com

Samedan Ltd

Specialist pharmaceutical publisher Samedan Ltd is a dynamic, forward-thinking company that produces a range of market-leading magazines for senior and middle-management professionals across the global pharma and life sciences sectors.

Established in 1996, it has four established print and digital titles: Pharmaceutical Manufacturing and Packing Sourcer, International Clinical Trials (incorporating European Pharmaceutical Contractor), European Biopharmaceutical Review and Innovations in Pharmaceutical Technology.

These analysis-driven magazines cover the latest trends and developments affecting our global audience of contract research, pharma and biotech practitioners - from early-stage research and clinical trials, to manufacture, supply and beyond. Regulatory compliance, operational considerations, outsourcing trends, market entry and cutting-edge technologies are among the many subjects covered.

In 2013, the company extended its range with the acquisition of the Pharmafile portfolio, consisting of the monthly newspaper Pharmafocus, www.pharmafile.com and the Pharmafile directory. A leading portal for the pharmaceutical sector, industry professionals can gain access to pharma news, events and service company listings.

In 2021, Samedan Ltd became part of PMGroup Worldwide Ltd and Datateam Media Group. The acquisition brings together three publishing powerhouses in the pharmaceutical and healthcare sector. As well as joining forces with established titles like PME, PharmaTimes and digital products PMLiVE and pharmatimes.com, PMGroup run a number of awards programmes which recognise best practice in the pharma and healthcare sectors. The union has allowed all brands to expand their readership and their live, virtual and hybrid events and award schemes.

www.samedanltd.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FlyPharma 2024: An Event to Remember here

News-ID: 3717136 • Views:

More Releases from Samedan Ltd

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors
FlyPharma 2025 Amsterdam officially announced as contracts are signed with host …
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond. In a first for FlyPharma, this year's event is supported by three host sponsors: Amsterdam Airport Schiphol, Air France
FlyPharma Vienna 2024: FlyPharma's Exclusive Gala Dinner, An Evening of Elegance and Networking
FlyPharma Vienna 2024: FlyPharma's Exclusive Gala Dinner, An Evening of Elegance …
In just two weeks, the industry leading FlyPharma Conference is set to return. Join industry professionals, expert speakers and delegates from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + Nagel and more, to tackle key challenges in global pharmaceutical logistics and supply chains. This unmissable event offers a unique platform for networking, discussion, and collaboration through expert-led sessions, insightful workshops, panel discussions, and
Agenda Announced for FlyPharma Vienna 2024!
Agenda Announced for FlyPharma Vienna 2024!
FlyPharma Vienna 2024's agenda is now live on the conference website. As the global pharmaceutical landscape continues to evolve at an unprecedented pace, FlyPharma remains at the forefront, set to address the critical collaboration of pharmaceuticals and air cargo. The highly anticipated conference, which takes place on 23-24 October 2024 at Office Park 4, Vienna AirportCity promises to deliver unparalleled insights, discussions, and solutions, spotlighting key topics that shape the current
FlyPharma Returns to Vienna for 8th European Conference
FlyPharma Returns to Vienna for 8th European Conference
FlyPharma, the platform for the pharmaceutical logistics and supply chain industry, is excited to announce its return to Vienna for its eighth European conference on 23-24 October 2024. Building on the success of last year's event, FlyPharma Vienna 2024 will bring together industry experts to delve deeper into the challenges and opportunities specific to the region, and further afield. Vienna's success as the host location for a very strong conference in

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the